Effect of Cellular Blood Components on Chemotherapy-Induced Alopecia

    Christina Stamatiou, Assuan Lens, Carmen Perez, Sylvia Daunert, Joaquín J. Jiménez
    TLDR Mononuclear cells may protect against certain chemotherapy-induced hair loss.
    The study investigated the protective effects of Mononuclear Cells (MC) and Platelet Rich Plasma (PRP) on chemotherapy-induced alopecia (CIA) using a young rat model. Three chemotherapeutic agents were tested: Ara-C, cyclophosphamide (CTX), and etoposide (VP-16). The control group received PBS, while other groups received PRP or MC. All groups developed complete body alopecia. MC provided excellent protection against CIA induced by Ara-C, likely due to IL-1 release, but offered no protection against CTX or VP-16. PRP did not protect against any chemotherapeutic agents. The study concluded that specific blood cells, particularly MC, may offer protection from CIA depending on the chemotherapy used.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 42 results

      community Hair greed made me switch to Dut too early

      in Chat  42 upvotes 3 weeks ago
      The user switched from finasteride to dutasteride for hair loss but faced increased shedding and anxiety, regretting not staying with finasteride longer. Other users shared mixed experiences, advising patience with dutasteride, as it may take up to a year to show results.

    Related Research

    2 / 2 results